🔴 Biovie is trading 13.09% down in pre-market with no clear company-specific catalyst identified

Biovie is trading at $1.50, down 13.09%, with no clear company-specific announcement explaining the November 4 pre-market decline. - The decline reverses part of the prior session’s 26.28% gain, when shares rose to $1.73. - BioVie’s latest identified news was its November 2 announcement of a Long COVID data presentation scheduled for November 5; it does not establish a direct cause. - Market context is mixed. A pullback after the sharp prior-session rise is possible, but unconfirmed.